• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传学在肿瘤影像学中的作用:放射组学研究中遗传验证数据的系统评价。

What Genetics Can Do for Oncological Imaging: A Systematic Review of the Genetic Validation Data Used in Radiomics Studies.

机构信息

Radiology Derpartment, Herlev og Gentofte Hospital, Borgmester Ib Juuls Vej 17, Opgang 4, 4.Etage, E2, 2730 Herlev, Denmark.

Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.

出版信息

Int J Mol Sci. 2022 Jun 10;23(12):6504. doi: 10.3390/ijms23126504.

DOI:10.3390/ijms23126504
PMID:35742947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9224495/
Abstract

(1) Background: Radiogenomics is motivated by the concept that biomedical images contain information that reflects underlying pathophysiology. This review focused on papers that used genetics to validate their radiomics models and outcomes and assess their contribution to this emerging field. (2) Methods: All original research with the words radiomics and genomics in English and performed in humans up to 31 January 2022, were identified on Medline and Embase. The quality of the studies was assessed with Radiomic Quality Score (RQS) and the Cochrane recommendation for diagnostic accuracy study Quality Assessment 2. (3) Results: 45 studies were included in our systematic review, and more than 50% were published in the last two years. The studies had a mean RQS of 12, and the studied tumors were very diverse. Up to 83% investigated the prognosis as the main outcome, with the rest focusing on response to treatment and risk assessment. Most applied either transcriptomics (54%) and/or genetics (35%) for genetic validation. (4) Conclusions: There is enough evidence to state that new science has emerged, focusing on establishing an association between radiological features and genomic/molecular expression to explain underlying disease mechanisms and enhance prognostic, risk assessment, and treatment response radiomics models in cancer patients.

摘要

(1) 背景:放射组学的概念是基于这样一种理念,即生物医学图像中包含反映潜在病理生理学的信息。本综述重点关注了那些利用遗传学来验证其放射组学模型和结果,并评估其对这一新兴领域贡献的论文。

(2) 方法:在 Medline 和 Embase 上搜索了截至 2022 年 1 月 31 日以英文发表的所有与放射组学和基因组学相关的原创研究,这些研究均在人类中进行。使用放射组学质量评分(RQS)和 Cochrane 诊断准确性研究质量评估 2 对研究质量进行评估。

(3) 结果:我们的系统综述共纳入 45 项研究,其中超过 50%的研究是在过去两年内发表的。这些研究的平均 RQS 为 12,研究的肿瘤种类非常多样化。高达 83%的研究将预后作为主要结局,其余研究则集中在治疗反应和风险评估上。大多数研究应用了转录组学(54%)和/或遗传学(35%)来进行遗传验证。

(4) 结论:有足够的证据表明,新的科学已经出现,其重点是建立放射学特征与基因组/分子表达之间的关联,以解释潜在的疾病机制,并增强癌症患者的预后、风险评估和治疗反应放射组学模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/dc835a9799d9/ijms-23-06504-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/ebbb3a9f4561/ijms-23-06504-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/f1371b2b4a54/ijms-23-06504-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/cf75283f2ae7/ijms-23-06504-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/6a387b0a9d09/ijms-23-06504-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/2c874a104548/ijms-23-06504-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/e7bfd7249f85/ijms-23-06504-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/2f8514bff7cb/ijms-23-06504-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/dc835a9799d9/ijms-23-06504-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/ebbb3a9f4561/ijms-23-06504-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/f1371b2b4a54/ijms-23-06504-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/cf75283f2ae7/ijms-23-06504-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/6a387b0a9d09/ijms-23-06504-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/2c874a104548/ijms-23-06504-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/e7bfd7249f85/ijms-23-06504-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/2f8514bff7cb/ijms-23-06504-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab2d/9224495/dc835a9799d9/ijms-23-06504-g008.jpg

相似文献

1
What Genetics Can Do for Oncological Imaging: A Systematic Review of the Genetic Validation Data Used in Radiomics Studies.遗传学在肿瘤影像学中的作用:放射组学研究中遗传验证数据的系统评价。
Int J Mol Sci. 2022 Jun 10;23(12):6504. doi: 10.3390/ijms23126504.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
5
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.

引用本文的文献

1
Advances in Molecular Research of Oncogenes.癌基因分子研究进展
Int J Mol Sci. 2023 Apr 13;24(8):7222. doi: 10.3390/ijms24087222.

本文引用的文献

1
The Usefulness of Radiomics Methodology for Developing Descriptive and Prognostic Image-Based Phenotyping in the Aging Population: Results From a Small Feasibility Study.影像组学方法在老年人群中开展基于图像的描述性和预后表型分析的实用性:一项小型可行性研究的结果
Front Aging. 2022 Apr 28;3:853671. doi: 10.3389/fragi.2022.853671. eCollection 2022.
2
Radiomic Analysis of Contrast-Enhanced MRI Predicts DNA Copy-Number Subtype and Outcome in Lower-Grade Gliomas.对比增强 MRI 的放射组学分析可预测低级别胶质瘤的 DNA 拷贝数亚型和预后。
Acad Radiol. 2022 Sep;29(9):e189-e196. doi: 10.1016/j.acra.2021.10.014. Epub 2021 Dec 14.
3
Radiogenomics and Artificial Intelligence Approaches Applied to Cardiac Computed Tomography Angiography and Cardiac Magnetic Resonance for Precision Medicine in Coronary Heart Disease: A Systematic Review.
应用于冠心病精准医学的心脏计算机断层扫描血管造影和心脏磁共振成像的放射基因组学与人工智能方法:一项系统综述
Circ Cardiovasc Imaging. 2021 Dec;14(12):1133-1146. doi: 10.1161/CIRCIMAGING.121.013025. Epub 2021 Dec 17.
4
A radiogenomics application for prognostic profiling of endometrial cancer.一种用于子宫内膜癌预后分析的放射组学应用。
Commun Biol. 2021 Dec 6;4(1):1363. doi: 10.1038/s42003-021-02894-5.
5
Integrative Radiogenomics Approach for Risk Assessment of Postoperative and Adjuvant Chemotherapy Benefits for Gastric Cancer Patients.用于评估胃癌患者术后及辅助化疗获益风险的整合放射基因组学方法
Front Oncol. 2021 Nov 5;11:755271. doi: 10.3389/fonc.2021.755271. eCollection 2021.
6
A comprehensive texture feature analysis framework of renal cell carcinoma: pathological, prognostic, and genomic evaluation based on CT images.基于 CT 图像的肾细胞癌的全面纹理特征分析框架:病理、预后和基因组评估。
Eur Radiol. 2022 Apr;32(4):2255-2265. doi: 10.1007/s00330-021-08353-3. Epub 2021 Nov 20.
7
Radiogenomics Map Reveals the Landscape of m6A Methylation Modification Pattern in Bladder Cancer.放射组基因组图谱揭示膀胱癌中 m6A 甲基化修饰模式的全景
Front Immunol. 2021 Oct 18;12:722642. doi: 10.3389/fimmu.2021.722642. eCollection 2021.
8
A Novel Radiogenomics Biomarker Based on Hypoxic-Gene Subset: Accurate Survival and Prognostic Prediction of Renal Clear Cell Carcinoma.基于缺氧基因子集的新型放射基因组学生物标志物:肾透明细胞癌的准确生存及预后预测
Front Oncol. 2021 Oct 7;11:739815. doi: 10.3389/fonc.2021.739815. eCollection 2021.
9
Biologic Pathways Underlying Prognostic Radiomics Phenotypes from Paired MRI and RNA Sequencing in Glioblastoma.胶质母细胞瘤配对 MRI 和 RNA 测序预后放射组学表型的生物学途径。
Radiology. 2021 Dec;301(3):654-663. doi: 10.1148/radiol.2021203281. Epub 2021 Sep 14.
10
Development and Validation of a Radiomic Nomogram for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma.用于预测肾透明细胞癌预后的影像组学列线图的开发与验证
Front Oncol. 2021 Jul 6;11:613668. doi: 10.3389/fonc.2021.613668. eCollection 2021.